Neurimmune Holding AG Overview

Life ScienceCompany

Where is Neurimmune Holding AG headquartered?

Neurimmune Holding AG is headquartered in Schlieren, Switzerland.

What sector is Neurimmune Holding AG in?

Neurimmune Holding AG is a life science company.

When was Neurimmune Holding AG founded?

Neurimmune Holding AG was founded in 2006.

Neurimmune Holding AG

Wagistrasse 13,
Schlieren, 8952
Switzerland,
+41 44 755 46 46
www.neurimmune.com

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases. Based on its unique RTM™ technology platform (Reverse Translational Medicine), Neurimmune pursues a novel and revolutionary approach for the development of proprietary human monoclonal antibodies as therapeutics with unique advantages that result in superior risk profiles and excellent efficacy.



Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Neurimmune Holding AG

Life Science Companies , Switzerland Companies